These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 25630418)

  • 1. Flap dynamics of plasmepsin proteases: insight into proposed parameters and molecular dynamics.
    Karubiu W; Bhakat S; McGillewie L; Soliman ME
    Mol Biosyst; 2015 Apr; 11(4):1061-6. PubMed ID: 25630418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flap flexibility amongst plasmepsins I, II, III, IV, and V: Sequence, structural, and molecular dynamics analyses.
    McGillewie L; Soliman ME
    Proteins; 2015 Sep; 83(9):1693-705. PubMed ID: 26146842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Dynamics Simulations of Ligand-Induced Flap Conformational Changes in Cathepsin-D-A Comparative Study.
    Arodola OA; Soliman ME
    J Cell Biochem; 2016 Nov; 117(11):2643-57. PubMed ID: 27038253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of flap flexibility of β-secretase using molecular dynamic simulations.
    Kumalo HM; Bhakat S; Soliman ME
    J Biomol Struct Dyn; 2016 May; 34(5):1008-19. PubMed ID: 26208540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative molecular dynamics study on BACE1 and BACE2 flap flexibility.
    Kumalo HM; Soliman ME
    J Recept Signal Transduct Res; 2016 Oct; 36(5):505-14. PubMed ID: 26804314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probing into the Flap-dimer Dynamics of the
    Adewumi AT; Oluyemi WM; Adewumi N; Adekunle YA; Alahmdi MI; Abo-Dya NE; Soliman MES
    Curr Top Med Chem; 2023; 23(12):1065-1080. PubMed ID: 36698229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computational analysis of aspartic protease plasmepsin II complexed with EH58 inhibitor: a QM/MM MD study.
    de Farias Silva N; Lameira J; Alves CN
    J Mol Model; 2011 Oct; 17(10):2631-8. PubMed ID: 21264482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The binding landscape of plasmepsin V and the implications for flap dynamics.
    L M; Soliman ME
    Mol Biosyst; 2016 Apr; 12(5):1457-67. PubMed ID: 26965894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyrrolidine derivatives as plasmepsin inhibitors: binding mode analysis assisted by molecular dynamics simulations of a highly flexible protein.
    Luksch T; Blum A; Klee N; Diederich WE; Sotriffer CA; Klebe G
    ChemMedChem; 2010 Mar; 5(3):443-54. PubMed ID: 20112327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structures of Ser205 mutant plasmepsin II from Plasmodium falciparum at 1.8 A in complex with the inhibitors rs367 and rs370.
    Asojo OA; Afonina E; Gulnik SV; Yu B; Erickson JW; Randad R; Medjahed D; Silva AM
    Acta Crystallogr D Biol Crystallogr; 2002 Dec; 58(Pt 12):2001-8. PubMed ID: 12454457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insight into selectivity of peptidomimetic inhibitors with modified statine core for plasmepsin II of Plasmodium falciparum over human cathepsin D.
    Dali B; Keita M; Megnassan E; Frecer V; Miertus S
    Chem Biol Drug Des; 2012 Apr; 79(4):411-30. PubMed ID: 22129033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. pH-Dependent Structural Dynamics of Cathepsin D-Family Aspartic Peptidase of
    Kang JM; Lê HG; Na BK; Yoo WG
    Pathogens; 2021 Sep; 10(9):. PubMed ID: 34578162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New parameterization approaches of the LIE method to improve free energy calculations of PlmII-Inhibitors complexes.
    Valiente PA; Gil A; Batista PR; Caffarena ER; Pons T; Pascutti PG
    J Comput Chem; 2010 Nov; 31(15):2723-34. PubMed ID: 20839299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting functional residues in Plasmodium falciparum plasmepsins by combining sequence and structural analysis with molecular dynamics simulations.
    Valiente PA; Batista PR; Pupo A; Pons T; Valencia A; Pascutti PG
    Proteins; 2008 Nov; 73(2):440-57. PubMed ID: 18442137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The protonation state of the catalytic aspartates in plasmepsin II.
    Friedman R; Caflisch A
    FEBS Lett; 2007 Aug; 581(21):4120-4. PubMed ID: 17689534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissection of the pH dependence of inhibitor binding energetics for an aspartic protease: direct measurement of the protonation states of the catalytic aspartic acid residues.
    Xie D; Gulnik S; Collins L; Gustchina E; Suvorov L; Erickson JW
    Biochemistry; 1997 Dec; 36(51):16166-72. PubMed ID: 9405050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pepsinogen-like activation intermediate of plasmepsin II revealed by molecular dynamics analysis.
    Friedman R; Caflisch A
    Proteins; 2008 Dec; 73(4):814-27. PubMed ID: 18498105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flap position of free memapsin 2 (beta-secretase), a model for flap opening in aspartic protease catalysis.
    Hong L; Tang J
    Biochemistry; 2004 Apr; 43(16):4689-95. PubMed ID: 15096037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystallographic evidence for noncoplanar catalytic aspartic acids in plasmepsin II resides in the Protein Data Bank.
    Robbins AH; Dunn BM; Agbandje-McKenna M; McKenna R
    Acta Crystallogr D Biol Crystallogr; 2009 Mar; 65(Pt 3):294-6. PubMed ID: 19237752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequence, Structural Analysis and Metrics to Define the Unique Dynamic Features of the Flap Regions Among Aspartic Proteases.
    McGillewie L; Ramesh M; Soliman ME
    Protein J; 2017 Oct; 36(5):385-396. PubMed ID: 28762197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.